Jefferies Group LLC Catalyst Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $24,942 - $54,832	3,533 Added 35.23%	13,560 $5,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $62,468 - $85,931	10,027 New	10,027 $3,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $61,856 - $96,803	-11,649 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $60,691 - $86,785	11,649 New	11,649 $35,000
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $38,210 - $76,274	-14,640 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$3.67 - $5.7 $31,341 - $48,678	-8,540 Reduced 36.84%	14,640 $55,000
Q3 2019 Nov 13, 2019	BUY	$3.89 - $7.43 $11,701 - $22,349	3,008 Added 14.91%	23,180 $123,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $54,464 - $123,250	20,172 New	20,172 $77,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.